Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Merck & Co Inc
Recent news which mentions Merck & Co Inc
< Previous
1
2
3
4
5
6
Next >
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Novartis AG
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Health & Science
Health care industry
Healthy Returns
From
CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
June 17, 2024
Tags
Pfizer Inc
Merck & Co Inc
US: News
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
AstraZeneca PLC
Health care industry
Healthy Returns
From
CNBC.com News
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
June 03, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
Tags
Health & Science
Moderna Inc
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Wednesday
May 29, 2024
Tags
Investing
Merck & Co Inc
5 Things to Know
From
CNBC.com News
Cramer says these 10 stocks helped the Dow briefly crack 40,000
May 16, 2024
Tags
American Express Co
Business News
Investment Strategy
From
CNBC.com News
Cramer explains how to maintain a 'balanced' portfolio as the economy slows
May 07, 2024
Tags
Amazon/com Inc
Builders FirstSource Inc
Meta Platforms Inc
From
CNBC.com News
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
April 25, 2024
Tags
Business News
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Microsoft Corp
Business
International Business Machines Corp
From
CNBC.com News
Cramer’s week ahead: Earnings from Tesla, Merck and Big Tech
April 19, 2024
Tags
Investment Strategy
Exxon Mobil Corp
Meta Platforms Inc
From
CNBC.com News
FDA approves Merck's drug for rare, deadly lung condition
March 26, 2024
Tags
Merck & Co Inc
US: News
Pharmaceuticals
From
CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
Tags
Akero Therapeutics Inc
Alphabet Inc
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
March 13, 2024
Tags
Biotech and Pharmaceuticals
Merck & Co Inc
Johnson & Johnson
From
CNBC.com News
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
March 10, 2024
Tags
Pharmaceuticals
Health & Science
Pfizer Inc
From
CNBC.com News
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
February 23, 2024
Tags
Pharmaceuticals
Health & Science
Health insurance
From
CNBC.com News
Moderna posts surprise quarterly profit even as Covid vaccines sales plummet
February 22, 2024
Tags
Companies
Breaking news
Health care industry
From
CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
February 13, 2024
Tags
Law and Regulation
Pharmaceuticals
Health & Science
From
CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
February 08, 2024
Tags
Prices
Politics
Congress
From
CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
February 02, 2024
Tags
Exxon Mobil Corp
Energy
Meta Platforms Inc
From
CNBC.com News
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
February 01, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
January 30, 2024
Tags
Biotech and Pharmaceuticals
Johnson & Johnson
Merck & Co Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Markets
Bristol/Myers Squibb Co
Boeing Co
From
CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
Tags
Merck & Co Inc
US: News
Johnson & Johnson
From
CNBC.com News
Cramer's week ahead: Fed meeting, labor report, Big Tech earnings
January 26, 2024
Tags
Stock Picks
Chevron Corp
Merck & Co Inc
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
Business News
Sanofi SA
Biotech and Pharmaceuticals
From
CNBC.com News
Dow goes from 37,000 to 38,000 in just 40 days. A history of the Dow and big round numbers
January 23, 2024
Tags
Investment strategy
Markets
Travelers Companies Inc
From
CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
Tags
Sanofi SA
Science
Business News
From
CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
Tags
Health care industry
Business
Breaking news
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.